This enduring, case-based activity will explore the role of screening and surveillance for patients with esophageal cancer (EC) and review clinical trial data on the efficacy and safety of immune checkpoint inhibitors as adjuvant treatment and across lines of therapy.
Release Date: May 21, 2021
Expiration Date: May 21, 2022
COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.
Release Date: May 28, 2021
Expiration Date: May 28, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.
Release Date: May 28, 2021
Expiration Date: May 28, 2022
This program will explore the use of vaccines and monoclonal antibody therapies for the prevention and treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of emerging vaccines and monoclonal antibodies, the rationale for early administration of monoclonal antibodies in recently infected and uninfected individuals, and compare active and passive immunity.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This program will explore the use of polyclonal and monoclonal antibody therapies for the treatment of patients with COVID-19. Innovative virtual reality animations will delve into the mechanism of action of antibody therapies, the impact of SARS-CoV-2 variants on treatment efficacy, and the role of dual monoclonal antibody cocktails in the prevention of viral escape.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This COVID-19 FRONTLINE Whiteboard Module will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic. We will focus on SARS-CoV-2 viral variants and emerging clinical data of their impact on vaccines and monoclonal antibodies currently authorized for emergency use. A whiteboard animation will be used to enhance the learning experience of this activity.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This COVID-19 Snapshot will explore the role of emerging SARS-CoV-2 variants and their potential impact on the efficacy of current monoclonal antibody therapies and vaccines authorized for emergency use in managing the COVID-19 pandemic.
In this module, we will discuss mutations in the spike protein of SARS-CoV-2 viral variants and the potential impact of these alterations on the efficacy of current vaccines and monoclonal antibodies authorized for emergency use management of the COVID-19 pandemic. We will also share resources and tools for the administration of monoclonal antibody infusion therapies, as well as programs and initiatives developed to improve the ease and access of diagnostic technologies across the United States.
Release Date: June 2, 2021
Expiration Date: June 2, 2022
This case-based online enduring will focus on treatment and management of patients with advanced/metastatic basal cell skin cancer.
Release Date: June 3, 2021
Expiration Date: June 3, 2022
This online activity will explore the management of patients with nontuberculous mycobacterial lung disease (NTM-LD), including diagnosis, therapy selection, and strategies for assessing and treating patients with refractory disease.
Release Date: June 3, 2021
Expiration Date: June 3, 2022
This case-based activity will cover the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis.
Release Date: June 16, 2021
Expiration Date: June 16, 2022
This enduring, case-based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health-related quality of life through burden of disease and associated comorbidities.
Release Date: June 16, 2021
Expiration Date: June 16, 2022
COVID-19 FRONTLINE podcasts provide a comprehensive and up-to-date perspective on the ever-changing management and prevention of COVID-19. Each podcast focuses on different issues facing clinicians and patients, such as managing patients with COVID-19, addressing the care of special populations during the pandemic, and coping with the long road to recovery.
Release Date: June 21 2021
Expiration Date: June 21, 2022
This online activity will explore best practices for the infusion of monoclonal antibodies in patients with mild-to-moderate COVID-19.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
This online activity will evaluate clinical trial data on the use of monoclonal antibodies for the treatment and prevention of COVID-19 and review up-to-date information on the impact of circulating SARS-CoV-2 variants on treatment efficacy.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
This online activity will explore best practices for the use of monoclonal antibodies for the treatment of COVID-19.
Release Date: June 25, 2021
Expiration Date: June 25, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.
Release Date: June 30, 2021
Expiration Date: June 30, 2022
This online activity will be a faculty-led didactic and case-based lecture focusing on treatment and management of patients with renal cell carcinoma.
Release Date: June 30, 2021
Expiration Date: June 30, 2022
Release Date: June 30, 2021
Expiration Date: June 30, 2022
This online activity will be a faculty-led didactic and case-based lecture focusing on treatment and management of patients with renal cell carcinoma.
Release Date: July 1, 2021
Expiration Date: July 1, 2022
The case-based online activity will cover the treatment and management of patients with TRK fusion-positive cancers.
Release Date: July 9, 2021
Expiration Date: July 9, 2022
The COVID-19 FRONTLINE VA Grand Rounds online activity provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19. The online session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic, and will focus on optimizing outcomes for hospitalized and non-hospitalized patients with COVID-19 through the use of novel agents authorized for emergency use.
Release Date: July 12, 2021
Expiration Date: July 12, 2022
This activity will cover the diagnosis and management of patients with influenza.
Release Date: July 15, 2021
Expiration Date: July 15, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 19, 2021
Expiration Date: July 19, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 19, 2021
Expiration Date: July 19, 2022
This enduring activity targets healthcare gaps related to the treatment and management of atrial fibrillation (AF), impacting outcomes through guidelines and best practices, appropriate antiarrhythmic use, and shared decision-making.
Release Date: July 20, 2021
Expiration Date: July 20, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in diabetic retinopathy (DR), which can impact vision-related quality of life.
Release Date: July 20, 2021
Expiration Date: July 20, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in age-macular degeneration (AMD), which can impact vision-related quality of life.
Release Date: July 21, 2021
Expiration Date: July 21, 2022
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
Release Date: July 21, 2021
Expiration Date: July 21, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: July 22, 2021
Expiration Date: July 22, 2022
This online activity targets healthcare gaps correlated with screening, multidisciplinary care and timely intervention in retinal vein occlusion (RVO), which can impact vision-related quality of life.
Release Date: July 27, 2021
Expiration Date: July 27, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This case-based live virtual activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: July 28, 2021
Expiration Date: July 28, 2022
This online activity is focused on the team involved in the management of patients with axial spondyloarthritis (AxSpa).
Release Date: July 31, 2021
Expiration Date: July 31, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: August 10, 2021
Expiration Date: August 10, 2022
This program provides a comprehensive and up-to-date perspective on the ever-changing management of patients with COVID-19 who present to the emergency department. The session features in-depth case studies to encourage retention of the lessons and provide new perspectives on the management of patients during the COVID-19 pandemic. The case studies will focus on different issues facing clinicians, such as identifying patients who would benefit from monoclonal antibody therapy and best practices for incorporating agents authorized for emergency use into the care of hospitalized and non-hospitalized patients with COVID-19. Strategies for administering neutralizing monoclonal antibodies, such as referral to local infusion centers or developing in-clinic infusion capabilities, will also be discussed.
Release Date: August 11, 2021
Expiration Date: August 11, 2022
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.
Release Date: August 20, 2021
Expiration Date: August 20, 2022
This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.
Release Date: August 26, 2021
Expiration Date: August 26, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This enduring activity will cover early detection and intervention in prostate cancer.
Release Date: August 30, 2021
Expiration Date: August 30, 2022
This activity will explore the management of patients with newly diagnosed, relapsed/refractory, and secondary acute myeloid leukemia (AML).
Release Date: September 7, 2021
Expiration Date: September 7, 2022
This case-based activity will cover the pathophysiology, point-of-care testing, and antiviral therapy for treating patients who present to the Emergency Department.
Release Date: September 16, 2021
Expiration Date: September 16, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
Release Date: September 17, 2021
Expiration Date: September 17, 2022
This enduring activity is focused on the team involved in the management of patients with familial hypercholesterolemia.
Release Date: September 20, 2021
Expiration Date: September 20, 2022
This enduring activity will cover the care and treatment of patients with moderate-to-severe atopic dermatitis.
Release Date: September 21, 2021
Expiration Date: September 21, 2022
This activity consists of presentations from expert faculty and 3D animation technology to discuss the pathology of small cell lung cancer (SCLC), clinical trial data of therapy in the second-line setting of SCLC, and clinical practice guidelines for the management of extensive disease.
RELEASE DATE: September 27, 2021
EXPIRATION DATE: September 27, 2022
This activity will cover the assessment, monitoring, and treatment of chronic lymphocytic leukemia (CLL) in the Department of Veterans Affairs.
Release Date: September 29, 2021
Expiration Date: September 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This online activity targets healthcare gaps related to the recognition, prevention, and management of diabetic retinopathy (DR). An expert panel discussion will guide you in identifying candidates for anti-VEGF therapy, review clinical trial data on the use of these agents, and provide evidence-based strategies to individualize the management of DR and overcome treatment barriers.
RELEASE DATE: October 01, 2021
EXPIRATION DATE: October 01, 2022
This activity consists of presentations from expert faculty and 2D animation technology to explain immune dysfunction and the pathogenesis of non-small cell lung cancer (NSCLC), currently available and emerging immuno-oncology used alone and in combination with chemotherapy for NSCLC, and the usefulness and application of biomarkers to guide treatment selection for NSCLC.
RELEASE DATE: October 06, 2021
EXPIRATION DATE: October 06, 2022
This enduring activity will review clinical trial data on the efficacy and safety of monoclonal antibodies and vaccines authorized for use in the treatment and prevention of COVID-19, and highlight and address healthcare disparities during the COVID-19 pandemic.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This program will explore the management of “off” episodes in patients with Parkinson’s disease. Interactive case studies presented by expert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 08, 2021
EXPIRATION DATE: October 08, 2022
This activity will cover the assessment, monitoring, and treatment of patients with severe uncontrolled asthma within the Department of Veterans Affairs.
RELEASE DATE: October 12, 2021
EXPIRATION DATE: October 12, 2022
PROGRAM CHAIR Robert Toto, MD Professor of Internal Medicine and Nephrology Director, Clinical Nephrology Director, Patient-Oriented Research in Nephrology Dallas, TX SPEAKING FACULTY Richard E. Pratley, MD Samuel E. Crockett
This case-based live-virtual activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 15, 2021
EXPIRATION DATE: October 15, 2022
This activity is designed to meet the educational needs of primarily dermatologists, onco-dermatologists, and also medical oncologists, Mohs surgeons, and other healthcare practitioners who care for patients with advanced/metastatic basal cell skin cancer.
RELEASE DATE: October 20, 2021
EXPIRATION DATE: October 20, 2022
This program will explore the management of off episodes in patients with Parkinson’s disease. Interactive case studies presented by ex pert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 21, 2021
EXPIRATION DATE: October 21, 2022
This live virtual symposium is focused on the team involved in the care of the people who undergo screening for cancer.
RELEASE DATE: October 22, 2021
EXPIRATION DATE: October 22, 2022
The case-based online activity will cover the treatment and management of patients with severe asthma.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This program will explore the use of systemic therapies for the management of moderate-to-severe atopic dermatitis in pediatric and adult patients.
RELEASE DATE: October 27, 2021
EXPIRATION DATE: October 27, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021
EXPIRATION DATE: October 29, 2022
This activity will cover the assessment, monitoring, and treatment of Acute Myeloid Leukemia (AML).
RELEASE DATE: November 12, 2021
EXPIRATION DATE: November 12, 2022
This enduring activity will cover the treatment and management of patients with moderate to severe asthma.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This activity will cover the assessment, monitoring, and treatment of patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas.
RELEASE DATE: November 16, 2021
EXPIRATION DATE: November 16, 2022
This case-based online activity will cover the treatment and management of patients with hepatocellular carcinoma (HCC).
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder.
RELEASE DATE: November 18, 2021
EXPIRATION DATE: November 18, 2022
This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.
RELEASE DATE: November 19, 2021
EXPIRATION DATE: November 19, 2022
In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.
RELEASE DATE: November 26, 2021
EXPIRATION DATE: November 26, 2022
The case-based online activity will cover the treatment and management of patients with chronic and diabetic kidney disease (DKD).
RELEASE DATE: November 30, 2021
EXPIRATION DATE: November 30, 2022
Upon the completion of this program, attendees should be able to:
RELEASE DATE: December 01, 2021
EXPIRATION DATE: December 01, 2022
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.
RELEASE DATE: December 07, 2021
EXPIRATION DATE: December 07, 2022
In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.
RELEASE DATE: December 21, 2021
EXPIRATION DATE: December 21, 2022
Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.
RELEASE DATE: December 21, 2021
EXPIRATION DATE: December 21, 2022
This enduring activity is a faculty-led didactic and case-based lecture focusing on the management of patients with gastric cancer and colorectal cancer.
RELEASE DATE: December 22, 2021
EXPIRATION DATE: December 22, 2022
This case-based online activity will help gynecologists and medical oncologists improve the timeliness of screening for women at risk for cervical cancer and the accuracy of diagnosis; and recognize the limitations of currently available regimens for recurrent and metastatic disease. The education will also seek to expand awareness of the integral role that the immune system plays in the pathology of cervical cancer and how IO agents in late-stage development for patients with recurrent or metastatic cervical cancer potentially could be integrated into practice once available.
RELEASE DATE: December 23, 2021
EXPIRATION DATE: December 23, 2022
This activity is designed to meet the educational needs of rheumatologists, rheumatology-related nurse practitioners, physician assistants and fellows.
RELEASE DATE: December 24, 2021
EXPIRATION DATE: December 24, 2022
RELEASE DATE: December 28, 2021
EXPIRATION DATE: December 28, 2022
This activity will explore strategies to improve glycemic and metabolic outcomes in patients with type 2 diabetes mellitus (T2DM). A review of clinical trial data will enable clinicians to personalize the selection of therapies for patients and examine the role of emerging dual GIP and GLP-1 receptor agonists in the management of type 2 diabetes and obesity.
RELEASE DATE: December 29, 2021
EXPIRATION DATE: December 29, 2022
This program is intended to help HCPs improve the diagnosis of SMA among older adolescent and adult patients and learn how the changing treatment landscape may alter patient outcomes.
RELEASE DATE: January 04, 2022
EXPIRATION DATE: January 04, 2023
This enduring activity is intended for dermatologists, pediatric dermatologists, and dermatology advanced providers (NPs and PAs) who are involved in the care and treatment of patients with alopecia areata.
RELEASE DATE: January 12, 2022
EXPIRATION DATE: January 12, 2023
RELEASE DATE: January 27, 2022
EXPIRATION DATE: January 27, 2023
This series of TeleECHO activities will discuss the management of patients with advanced and/or metastatic (m) renal cell carcinoma (RCC) and therapeutic options available in the first line setting.
RELEASE DATE: January 28, 2022
EXPIRATION DATE: January 28, 2023
RELEASE DATE: January 31, 2022
EXPIRATION DATE: January 31, 2023
This case-based online activity is designed to provide clinicians with an overview of prurigo nodularis (PN), the importance of early diagnosis, and our latest understanding of the management options for the disease.
RELEASE DATE: February 08, 2022
EXPIRATION DATE: February 08, 2023
RELEASE DATE: February 10, 2022
EXPIRATION DATE: February 10, 2023
This program will review immunotherapies for the first-line management of patients with advanced NSCLC.
RELEASE DATE: February 10, 2022
EXPIRATION DATE: February 10, 2023
RELEASE DATE: February 16, 2022
EXPIRATION DATE: February 16, 2023
This activity is designed to help lipidologists, cardiologists, and other healthcare professionals involved in the management of US veterans with familial hypercholesterolemia (FH) to improve cholesterol and cardiovascular outcomes for veteran patients.
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This enduring activity is a faculty-led didactic and case-based lecture focusing on the management of patients with hepatocellular carcinoma (HCC).
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This activity provides a practice-based learning experience for dermatologist and primary care physicians regarding the assessment and treatment of alopecia areata (AA). By participating in this Simulation Center, learners will observe an interaction between a physician and their patient with AA and will test their knowledge of diagnosis and management at key decision points along the way. The burden of AA and its associated comorbidities will be highlighted, and you will learn strategies to effectively address the psychosocial impacts of this disease with your patients.
RELEASE DATE: February 23, 2022
EXPIRATION DATE: February 23, 2023
This enduring activity focuses on the treatment and management of patients with generalized myasthenia gravis (gMG).
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This enduring activity is designed to review early identification strategies for MS; assess the variety of treatments available to treat the condition; and discuss ways to improve adherence, engagement, and clinician/patient communication.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This activity will help participants to overcome clinical inertia and other potential barriers to timely and appropriate insulin therapy in patients with type 2 diabetes. Participants will be equipped with an enhanced ability to select, titrate and adjust basal insulin regimens, and to successfully educate and empower their patients to self-manage their diabetes.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
This CME activity will help participants identify the characteristics of older adults with type 2 diabetes that require special consideration, assess older patients with type 2 diabetes, and develop personalized pharmacotherapeutic strategies for older patients with type 2 diabetes, both in the community and in long-term care, that include the use of fixed-ratio GLP-1 receptor agonist/insulin combinations. The activity features a Situation Room, a unique online program which employs a patient simulation platform. The situation room provides interactive quizzing, testing, and training via immersion-focused 3D simulations of scenarios encountered by clinicians who care for older adults with type 2 diabetes. The experience will be customized based on who is using the simulation. One track will be aimed at geriatricians and endocrinologists, and the other will be aimed at PCPs, physician extenders and consultant pharmacists. A slide presentation will guide the learners in their selection of treatment strategies.
RELEASE DATE: February 25, 2022
EXPIRATION DATE: February 25, 2023
RELEASE DATE: February 28, 2022
EXPIRATION DATE: February 28, 2023
This enduring activity will discuss the causes of alopecia areata and how to best manage this disease. Expert faculty will highlight the burden of alopecia areata and will offer participants strategies for implementing treatment plans that will not only address the disease itself, but also the overall health challenges for this patient population.
RELEASE DATE: March 02, 2022
EXPIRATION DATE: March 02, 2023
This case-based enduring activity is designed to help community oncologists and the multidisciplinary care team choose the optimal treatment for chronic lymphocytic leukemia (CLL) based on patient and disease characteristics, including performance status, organ function, comorbidities, drug interactions, and genetic and molecular biomarkers; monitor for and manage adverse events; and implement SDM into clinical practice to improve patient care and QoL.
RELEASE DATE: March 04, 2022
EXPIRATION DATE: March 04, 2023
This enduring TeleECHO program will explore the management of patients with advanced endometrial cancer through interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing and discuss the management of adverse events with immune-oncology/tyrosine kinase inhibitor combination therapies.
RELEASE DATE: March 04, 2022
EXPIRATION DATE: March 04, 2023
This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations, case presentations, and a pre-recorded Q&A session.
RELEASE DATE: March 09, 2022
EXPIRATION DATE: March 09, 2023
This activity will explore the management of pediatric and adult patients with moderate-to-severe atopic dermatitis through interactive case-based simulations. Expert faculty will review strategies on how to personalize the selection of systemic treatment options based on guideline recommendations, evidence-based best practice, and emerging clinical trial data. Case-based simulations will help learners identify candidates for systemic therapy and address safety and quality of life issues.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring program is designed for allergists, otolaryngologists, primary care clinicians, and other clinical team members who manage chronic rhinosinusitis with nasal polyps. In this program, we will aim to discuss the burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach clinicians how to apply best practices for the interdisciplinary development of individualized treatment plans for these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach clinicians who manage this condition.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.
RELEASE DATE: March 11, 2022
EXPIRATION DATE: March 11, 2023
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder.
RELEASE DATE: March 16, 2022
EXPIRATION DATE: March 16, 2023
This enduring virtual activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of AD, impacting outcomes through identifying burdens affecting quality of life, assessing disease severity when considering topical vs systemic intervention, and utilizing strategies in shared decision-making when determining guideline-based care.
RELEASE DATE: March 28, 2022
EXPIRATION DATE: March 28, 2023
This enduring TeleECHO program will explore the management of ocular toxicities and other adverse events related to treatment of relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss how and why these adverse events occur. The importance of Risk Evaluation and Mitigation Strategy (REMS) programs for monitoring your patients for corneal changes and other effects of later-line therapy for multiple myeloma will also be presented. Interactive case studies will illustrate strategies for choosing therapy and for managing treatment-related adverse events in the RRMM setting.
RELEASE DATE: March 28, 2022
EXPIRATION DATE: March 28, 2023
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
The online activity will address renoprotective therapies in care of patients with T2D and CKD with a focus on mineralocorticoid receptor antagonists and SGLT2 inhibitors. Discussion will include mechanisms of action, emerging clinical data, best practices in screening patients, and management considerations for hyperkalemia.
RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023
This enduring TeleECHO activity will explore the use of JAK inhibitors for the management of rheumatoid arthritis (RA) through interactive case studies. Faculty will review emerging efficacy and safety data, discuss guideline recommended care of RA, and help clinicians identify candidates for treatment with JAK inhibitors.
RELEASE DATE: April 04, 2022
EXPIRATION DATE: April 04, 2023
This enduring activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of hepatorenal syndrome with acute kidney injury (HRS-AKI), impacting outcomes through diagnosis and differentiation from other forms of AKI as well as individualizing pharmacotherapeutic management.
RELEASE DATE: April 05, 2022
EXPIRATION DATE: April 05, 2023
This educational activity will explore the use of monoclonal antibodies for the treatment and prevention of COVID-19 in pediatric patients. A review of available clinical data will help clinicians identify candidates for therapy and select appropriate treatments based on the most up-to-date information.
RELEASE DATE: April 08, 2022
EXPIRATION DATE: April 08, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
In this episode, a pediatric infectious disease specialist will clarify when to use monoclonal antibodies in pediatric patients with COVID-19 and discuss ways to overcome challenges in administering therapy.
RELEASE DATE: April 11, 2022
EXPIRATION DATE: April 11, 2023
In this comprehensive and interactive CME activity, we will be presenting important topics in the area of diabetic kidney disease. The program includes slide-based material interspersed with interactive questions and case studies to enhance learning. The focus is on kidney disease in the diabetic patient, specifically mechanisms of disease, diagnosis and evaluation, and therapeutic options.
RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023
This enduring virtual activity targets healthcare gaps related to the treatment and management of AD in urban communities, impacting outcomes through identifying determinants that impact health in urban communities, implementing strategies in disease severity assessment across varying skin tones, and guideline-based care.
RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023
This interactive global educational activity is designed to help oncologists, pathologists, surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) to improve their knowledge of the disease, best practices for treatment, and the role of immunotherapy in managing non-melanoma skin cancer (NMSC).
RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023
In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach pharmacists who see this condition.
RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023
This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline recommended step-care management, and efficacy and safety of current and emerging biologic therapy.
RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023
The acute myeloid leukemia (AML) TeleECHO enduring program will explore strategies to promptly recognize, diagnose, and manage AML. This TeleECHO enduring provides a didactic programming in addition to case-based discussion on selecting therapeutic options and managing patients with AML.
RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023
This enduring TeleECHO educational series targets healthcare gaps related to the familiarity and understanding of CDK4/6 inhibitor clinical trial designs and results on efficacy, safety, and real-world studies, impacting outcomes through current practice patterns and treatment strategies in the management of HR+/HER2- metastatic breast cancer (mBC).
RELEASE DATE: May 04, 2022
EXPIRATION DATE: May 04, 2023
This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. An animated case will allow learners to apply what they have learned in a simulated clinical encounter.
RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023
This enduring activity focuses on the treatment and management of cold agglutinin disease.
RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023
This case-based online enduring activity will cover the treatment and management of patients with Type 2 diabetes mellitus (T2D) who are at high risk for chronic kidney disease.
RELEASE DATE: April 28, 2022
EXPIRATION DATE: April 28, 2023
COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.
In this episode, an emergency medicine physician will discuss strategies for the administration of monoclonal antibodies in adult and pediatric patients in an emergency department setting.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This educational activity will assess the pathophysiology and disease domains of psoriatic arthritis as well as review FDA-approved agents and their roles in in treating the disease. Additionally, we will discuss the appropriateness of combination or monotherapy regimens and unanswered questions in this area.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This enduring activity targets healthcare gaps related to the early intervention of retinal vascular diseases and familiarity with new and emerging clinical trial data, impacting outcomes through assessment and synthesis of clinical trial structures, and outcomes of studied anti-VEGF agents for incorporation into treatment strategy development.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This online activity will cover the pneumococcal vaccinations in specific populations.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This live virtual activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This enduring activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
This activity provides a practice-based learning experience for medical oncologists, pulmonologists, nurse practitioners, and other health care providers, regarding the assessment and treatment of non-small cell lung cancer (NSCLC) in the first-line setting. By participating in this Simulation Center, learners will observe an interaction between a patient with NSCLC and their healthcare provider, and will test their knowledge of diagnosis and management at key decision points along the way.
RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023
Pneumococcal disease caused by Streptococcus pneumoniae is the leading cause of pneumonia-related deaths and poses an important global public health concern. There are several vaccines available for prevention of this disease, but their implementation in the clinic is challenged by complex recommendations of their administration for various patient populations and by complicated guidelines for appropriate spacing and sequencing of vaccine schedules. Managed Care Specialists need to understand the nuances of pneumococcal vaccines to guide physicians on their appropriate use to reduce infections and improve clinical outcomes, particularly for at-risk patients. This educational activity will explore the impact of pneumococcal disease, pathophysiology of disease, guidelines recommendations, and strategies for managing vaccine hesitancy. In addition to a didactic presentation, the program features animations and case discussions to highlight the different aspects of this disease.
RELEASE DATE: May 10, 2022
EXPIRATION DATE: May 10, 2023
This program will discuss the nuances of EGFR-mutated non-small-cell lung cancer and the impact of genomic and metabolic pathways for treatment selection.
RELEASE DATE: May 11, 2022
EXPIRATION DATE: May 11, 2023
This online activity with an integrated case-based learning component will enable clinicians to recognize emerging targets in the management of anemia of chronic kidney disease (CKD) through an understanding of the underlying pathophysiology and clinical trials evaluating novel therapies. By integrating these data with the current standards of care in the management of anemia of CKD, clinicians will be better able to understand the role of multiple healthcare professionals in the management of this common complication of CKD. Additionally, the integrated case-based activity within this program will ensure that healthcare professionals can readily translate learnings to patient interactions, ensuring that patients and the healthcare team are aware fully aware of emerging therapeutic alternatives.
RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023
Through a series of informative lectures and podcast interviews, this educational series will target clinicians in the field of rheumatology who have patients with psoriatic arthritis. We will provide the latest information on clinical presentation, differential diagnosis, therapeutic targets, and clinical trial data on current and emerging therapies to help learners reduce both short- and long-term consequences of the disease.
RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023
Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.
Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.
Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.
